OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Molecular Medicine is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Advisory Board and Contents	269
Subscription and Copyright Information	211
Subscription and Copyright Information	194
Advisory Board and Contents	179
Stories in Molecular Medicine December 2021	176
Advisory Board and Contents	170
Subscription and Copyright Information	148
Advisory Board and Contents	126
Subscription and Copyright Information	110
Subscription and Copyright Information	110
Pre-eclampsia: Challenges for Nanomedicine Development in Pregnancy	107
Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates	105
Bursts of brain erosion: seizures and age-dependent neurological vulnerability	102
Consideration of the importance of measuring thermal discomfort in biomedical research	98
Fc-optimized checkpoint antibodies for cancer immunotherapy	92
Neutrophils and extracellular traps in crystal-associated diseases	91
Opportunities and challenges for biomarker discovery using electronic health record data	87
Cellular senescence in neuroinflammatory disease: new therapies for old cells?	84
Pushing the boundaries of brain organoids to study Alzheimer’s disease	84
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes	79
Beneath the radar: immune-evasive cell sources for stroke therapy	78
d-Amino acids: new clinical pathways for brain diseases	76
Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors	72
Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines	70
m6A and beyond: RNA modifications shaping angiogenesis	69

Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models	68
Subscription and Copyright Information	65
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers	65
Stories in Molecular Medicine November 2021	65
Engineering cytokines for tumor-targeting and selective T cell activation	60
Insights from HIV-1 vaccine and passive immunization efficacy trials	59
Alternative Polyadenylation in Stem Cell Self-Renewal and Differentiation	57
Acquired resistance to immunotherapy in solid tumors	57
Cell-free circulating tumor DNA profiling in cancer management	56
Brain-specific regulatory T cell expansion limits cognitive decline	56
Emerging roles of cyclin-dependent kinase 7 in health and diseases	53
Microbes and mood: innovative biomarker approaches in depression	52
Advisory Board and Contents	49
Erythropoietic protoporphyrias: updates and advances	48
Skeletal muscle mitochondrial network dynamics in metabolic disorders and aging	47
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality	47
iPSCs and DRGs: stepping stones to new pain therapies	46
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients	46
Molecular mechanisms in the pathogenesis of dengue infections	44